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The amniotic membrane (AM) has many desirable qualities for tissue engineering. The three main 
objectives of this study were to investigate 1) adipose-derived stem cell (ASC) cultivation and 
possible differentiation on AM, 2) co-cultivation of ASCs and human umbilical vein endothelial 
cells (HUVECs) on AM for enhanced angiogenesis, 3) effects of cell cultivation on the mechanical 
properties of AM. 
Denuded AM was cut and placed to cover the bottom of 6-well multidishes, 1/3 of AM-covered 
wells were seeded with only ASCs, 1/3 with only HUVECs and 1/3 with both. Half were cultured 
with adipose medium (ADM) and half with endothelial medium for three weeks (EM). 
After three weeks, the cultivated AMs were analyzed with quantitative real-time polymerase chain 
reaction (RT-PCR), immunofluorescence photography, hematoxylin-eosin staining and 
microtomography. Tensile strength tests were conducted with separate AM samples cultivated in 
special scaffolds along with nitrocellulose paper. 
Results showed no visible adipose formation, nor clear angiogenic tube formation. Engineering 
stress endured by AM during tension testing decreased as cultivation time lengthened. ASCs 
showed great viability on AM. HUVECs showed viability in EM based on von Willebrand factor 
expression. HUVEC proliferation was not seen in ADM. In conclusion, AM is a suitable scaffold 
for ASCs, better induction agents for adipocyte differentiation and tube formation should be 
explored, and a better method to detect HUVECs from the co-cultivation wells is needed. 
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1. Introduction 
	
	
1.1. Tissue engineering 
 
Tissue engineering and regenerative medicine rose to prominence in the late 1980s as other treatment options 
for organ failure and tissue loss proved less efficient and more problematic than imagined. The queue for 
organ transplantation was long and allogeneic transplantation caused immunological rejection in some 
recipients. Artificial materials and mechanical devices i.e. artificial joints, dialysis machine, were too simple 
to replace all functions of a human organ (1).  
The basis of tissue engineering is the production of new tissue through cultivation of isolated cells in tissue-
inducing substances e.g. growth factors in matrix or on scaffolding (Figure	1) (1).  
 
Figure	1	-	Principles	of	tissue	engineering	(2) 
 
Virtually every tissue and organ of the human body has been the subject for tissue engineering e.g. bone, 
cartilage, muscle, skin and spinal cord to name a few (2). Stem cells have always been a subject of interest in 
tissue engineering since they can differentiate into multiple cell lines, thus can be tailored individually for 
each application (3).  
Different matrix materials have been tested, from synthetic materials such as lactic-glycolic acid or 
polyacrylonitrile-polyvinyl chloride to natural materials like collagen or hydroxyapatite. The mechanical 
properties of synthetic materials are easier to control; natural materials on the other hand mimic in-vivo 
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extracellular matrix in which the cultivated cells can be naturally found. (3) In this study, the suitability of 
amniotic membrane (AM) as a tissue engineering scaffold will be examined.  
 
1.2. Amniotic membrane 
 
The amniotic membrane is one of the two fetal membranes, the other being the chorion. The membranes are 
formed during early embryo development, around the 8th -9th day of gestation. AM lines the amniotic cavity, 
which is full of amniotic fluid. The amniotic fluid is partly produced by the cells of the AM, but mostly it is 
derived from maternal blood. The embryo and later on fetus, is immersed in the fluid, which absorbs jolts 
and allows fetal movement inside the mother. The amniotic cavity lies within the chorionic cavity, as the 
amnion grows, it fills the chorionic cavity completely. Even though AM covers the chorion from the inside, 
the two membranes stay separated instead of fusing (4). 
 
 
AM is usually 0.02-0.5cm thick, and is consisted of five histologically different layers: epithelium, basement 
membrane, compact layer, fibroblast layer and spongy layer in the order of from the amnion cavity to the 
chorion (Figure	2) (5) . The last three layers are sometimes categorized as one, called the avascular stromal 
layer. The fibroblast layer contains amniotic mesenchymal cells, which are responsible for matrix formation. 
Figure	2	-	Layers	of	the	amniotic	membrane	and	chorion		(57)	 
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Unlike chorion. AM has no blood vessels or nerves and receives its nutrition by diffusion either from the 
amniotic fluid or the maternal decidua (6).   
 
AM was first used by Davis (7) for skin transplantations in 1910. Since then, AM has been widely applied in 
different fields of medicine including burn treatment, ocular reconstruction and many types of reconstructive 
surgery (8). AM’s popularity as a scaffold is due to its many desirable characteristics for tissue engineering. 
Firstly, amniotic epithelial cells (AEC) are pluripotent and clonogenic, making them a good source of stem 
cells (6). Secondly, studies suggest AM is immunologically inert due to AECs lacking certain surface 
antigens, such as human leukocyte antigens (HLA) -A, -B, -D and –D related (DR) (9). AECs and amniotic 
mesenchymal cells also secrete various anti-inflammatory proteins, among them interleukin-1 receptor 
antagonist (IL-1ra) and IL-10, which inhibit the production of pro-inflammatory factors (10). AM stromal 
matrix also has a suppressive effect on the IL-1 gene family, which expresses some of the most important 
pro-inflammatory factors (11). The low immunogenicity of AM reduces the risk of rejection or immune 
reaction upon transplantation (9). Thirdly, AM acts as a promoter of epithelial migration, adhesion, 
differentiation, and prevents apoptosis (8). Fourthly, AM is believed to down-regulate transforming growth 
factor beta (TGF-β) and its receptor, thus reducing fibrosis and scarring (12). AM is also non-tumorigenic 
and believed to have pain analgesic effects (13).   
When used in tissue engineering, the epithelial cells of AM is usually left intact, since the single layer of 
cuboidal cells is responsible for many of the characteristics that make AM a good scaffold. Studies using 
acellular AM have also been conducted, in which e.g. fibroblasts and keratinocytes not only adhered to AM 
acceptably, but also showed good morphology and viability (13,14). 
 
1.3. Stem cells 
	
The two defining characteristics of stem cells are the ability to self-renewal and the capacity to differentiate 
into multiple cell types. These properties make stem cells very attractive for regenerative medicine, since one 
cell line can be used to produce endless copies of many cell types. Stem cells have been used successfully in 
treating e.g. leukemia. Future uses of stem cells include the treatment of a number of degenerative diseases 
i.e. type I diabetes, multiple sclerosis, Parkinson’s disease etc. (15) 
The origin of the stem cell defines its potential for differentiation, which can be divided into three categories 
(Figure	3). Totipotent stem cells (TSCs) can differentiate into any cell of the body and also into trophoblasts, 
which make up the placenta. Natural TSCs can be found in embryos at the one or two cell stage. Pluripotent 
stem cells (PSCs) can differentiate into any cell of the body, but not trophoblasts. PSCs can be found in 
embryos past the one and two cell stage. PSCs also include induced pluripotent stem cells (iPSCs), which are 
generated from differentiated, somatic cells. Multipotent stem cells can differentiate into any cell of a 
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specific organ or tissue type e.g. hematopoietic stem cells can differentiate into all blood cells. Multipotent 
stem cells are often called adult stem cells, since they have been found in various tissues of the adult body. 
The term somatic stem cell (SSC) is preferred, since multipotent stem cells are formed in the fetal stage of 
development. One of the most studied multipotent stem cell lineages is mesenchymal stem cell (MSC). 
MSCs can be found in stroma, such as bone marrow, adipose tissue, synovial tissue, amniotic fluid, placenta 
and umbilical cord blood, and can differentiate into cell types such as osteocytes, adipocytes, chondrocytes, 
neurocytes, epithelial and endothelial cells. (15) MSCs were first discovered in bone marrow, presently 
MSCs are commonly harvested from adipose tissue and umbilical cord blood, since bone marrow collection 
is invasive and can be painful (16,17) 
The use of TSCs and PSCs is ethically controversial since it involves the destruction of human embryos. The 
same problem is not present when using SSCs, since they can be harvested from consenting individuals 
without causing them bodily harm e.g. through collection of medical waste such as adipose tissue after 
liposuction and umbilical cord after birth. (18)  Embryonic stem cells (ESCs) can also be problematic since 
undifferentiated ESCs can form teratomas in the recipient if the transplant material is not completely 
removed of the undifferentiated ESCs. The downside of SSCs is that they are hard to distinguish from 
progenitor cells, since adequate assays for SSC recognition has not been developed for a number of tissues. 
(19) 
 
Figure	3	-	Hierarchy	of	stem	cells		(58)	 
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1.3.1. Adipose-derived stem cells 
	
Adipose-derived stem cells (ASCs) are somatic stem cells found abundantly in the adipose tissue of the adult 
human body (20). By manipulating the adipose tissue, differentiated adipocytes can be removed, and ASCs 
can be sourced from the remaining stromal vascular fraction (SVF) (21) . 
Since ASCs are of stromal origin (21), they can be classified as mesenchymal stem cells (MSCs). Studies 
show that MSCs in general have an anti-inflammatory effect on the immune system, which makes them a 
good candidate for cellular therapy. (22)  Compared to the first MSCs found in the bone marrow (BM-
MSCs) (23) , ASCs may be a more suitable choice for regenerative medicine. While bone marrow harvesting 
is painful and can lead to complications, adipose tissue is largely available in the human body, and ASCs can 
be easily harvested from adipose tissue waste resulting from different surgeries e.g.liposuction. The amount 
of MSCs that can be collected from bone marrow harvest is also relatively lower than the amount of ASCs 
that can be collected from adipose tissue (24). While some differences between BM-MSCs and ASCs have 
been found i.e. gene expression profile and angiogenic potential, the significance of the differences remain 
uncle1ar (25).  
Due to the abundance of ASCs and its multipotent stem cell nature, ASCs are an attractive candidate in the 
field of wound healing and tissue regeneration. ASCs have been found to secrete almost all of the growth 
factors that take part in wound healing, i.e. keratinocyte growth factor, vascular endothelial growth factor 
(VEGF), hepatocyte growth factor, fibroblast growth factor-2, epidermal growth factor, and platelet-derived 
growth factor, and that the expression of the factors can be increased by preconditioning the cells via 
hypoxia. The use of ASCs has not been reported to cause significant immunogenicity in hosts, xenografts 
and allografts alike. Various different ASC delivery methods to wound sites have been tested, including local 
injection, topical application, collagen gel and fibrin sealant. Consensus on the best method has yet to be 
reached due to the lack of comparative studies. The application of ASCs in problematic wounds e.g. diabetic, 
ischemic and radiated tissue has also shown potential. (26) 
 
1.3.2. Human umbilical vein endothelial cells 
	
Human umbilical vein endothelial cells (HUVECs) are harvested after birth from the epithelium of the 
umbilical vein, which is usually discarded as medical waste. One of the most attractive features of HUVECs 
is their ability to vascularize engineered tissue constructs, which otherwise will go into necrosis without 
sufficient nutrient and oxygen supplies. e.g. biomimetic bone tissue has been fabricated using MSCs and 
HUVECs. (27) In another study, the co-cultivation of MSCs and HUVECs on poly(LLA-co-DXO) scaffolds 
in a 5:1 ratio resulted in a more quiescent phenotype of HUVECs, meaning less proliferation. But at the same 
time MSCs were found to express significantly more vascular endothelial growth factor A (VEGFa) than 
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HUVECs alone. The study found that the scaffolds containing both MSCs and HUVECs produced higher 
density of mature vessels compared to HUVECs alone. It was concluded that MSCs could be a suitable 
candidate for perivascular cells when engineering blood vessels. (28)   
HUVECs have been also used to produce iPSCs, since they lack the ethical issue of ESCs and are better than 
aged somatic cells, which possess less telomerase activity and contain more nuclear and mitochondrial 
mutations(29).  
 
1.4. Objectives and expected results 
	
The objective of this study was to create 3D-grafts of AM with adipose tissue and vascular formation 
through tissue engineering by cultivating ASCs and HUVECs on top of denuded (epithelium removed) AM. 
The grafts would either allow direct transplantation or enable in vitro examination of adipose tissue. To 
achieve this, we investigated the cultivation by measuring the expression of AP2, PPAR-γ, vWF and 
ANGPT1 with quantitative real-time polymerase chain reaction (qPCR). Immunocytochemistry staining, 
micro-CT and histological analysis were also conducted. The mechanical properties of AM after ASC 
cultivation were examined through tensile strength tests in Tampere University of Technology.  
Vascularization remains an obstacle in tissue engineering, since constructs will go into necrosis without 
sufficient oxygen and nutrient supply. HUVECs were introduced to the cultivation in hopes of angiogenesis 
and the co-cultivation along ASCs was expected to promote vessel formation. The tensile strength of AM 
after cultivation was expected to increase due to the new cell structures. 
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2. Materials and methods 
	
	
2.1. Tissues and cells 
	
This study was conducted in accordance of the Ethics Committee of the Pirkanmaa Hospital District, 
Tampere, Finland (R06045, R15161, R13019). 
The amniotic membranes were collected from donor placentas after scheduled C-sections to avoid 
contamination at Tampere University Hospital. Vaginal deliveries have been shown to increase the 
possibility of bacterial contamination of AM and thus scheduled C-sections are preferred in general as a 
harvesting method. The donors were screened for syphilis, HIV and hepatitis B and C.  
The ASCs were collected from discarded adipose tissue after surgeries performed at Tampere University 
Hospital. The ASC donors were otherwise healthy and non-diabetic  
The HUVECs were collected from umbilical cords originated from scheduled C-sections at Tampere 
University Hospital.  
 
2.2. Cultivation of cells on AM 
	
2.2.1. Isolation and culture of cells 
	
Both ASCs and HUVECs were collected using the methods described by Sarkanen et al. (30,31) . The cells 
were cryopreserved after collection and defrosted when needed. After defrosting, the cells were seeded into 
75cm2 culture flasks along with 10ml of medium. ASCs received basic medium (BM) (Dulbecco’s Modified 
Eagle’s Medium/F12 [Invitrogen Ltd.], 5% human serum [Cambrex], 1% L-glutamine [Invitrogen Ltd.], and 
1% penicillin-streptomycin mixture [Invitrogen Ltd.]). HUVECs received endothelial medium (EM) (EGM 
kit [Lonza]: endothelial growth basal medium, 2% human serum, 0,1% VEGF, 0,1% R3-IGF-1, 0,1% GA-
1000, 0,1% heparin, 0,01% hEGF, 0,4% hFGF-2, 0,04% hydrocortisone, 0,1% ascorbic acid). The cells were 
cultured and divided until the desired cell amount was reached. The media were changed twice a week. 
ASCs usually received a half medium change, since the cells showed great vitality. HUVECs received total 
medium changes, due to the large amount of dead cells. Despite the large amount of dead HUVECs at each 
medium change, the cells still proliferated well and had no problem covering the bottom of the culture flask. 
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Due to the angiogenetic nature of HUVECs, the cells were labeled with ultrasmall superparamagnetic iron 
oxide (USPIO) particles (diameter approximately 30nm) to enable imaging of the possible vessel formation 
with micro-CT.  
A list of ASC and HUVEC cell lines cultured for this study and their respective analysis can be found in 
Error! Reference source not found.. The expressions of different surface markers of both ASC cell lines 
are listed in Table 2. 
	
Table	1	-	List	of	cultured	cell	lines	and	their	respective	analysis 
Cell line   Analysis 
ASC 2/14 P4 qPCR 
ASC 2/14 P2 + HUVEC 1 P8 USPIO Micro-CT + HE histology 
ASC 2/14 P4  Tensile strength 
ASC 2/14 P3 + HUVEC 1 P10 USPIO x 2 multidish qPCR (1 multidish) + micro-CT + HE histology (1 
multidish) 
ASC 2/15 P2 + HUVEC 1 P8 USPIO x 24-well 
microplate 
Immunofluorescence photography (test round, sans 
AM) 
ASC 2/15 P5 + HUVEC 1 P10 USPIO x 4 multidish qPCR 
ASC 2/15 P9 + HUVEC 1 P13 USPIO x 2 multidish Immunofluorescence photography 
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Table	2	-	Cell	surface	markers	of	ASC	2/14	and	2/15	
Antigen Surface protein Expression 
2/14 (2/15) 
Fluorophore Manufacture 
CD3 T-cell surface 
glycoprotein 
0,2 (0,5) phycoerythrin (PE) BD Biosciences, 
Franklin Lakes, NJ, 
USA 
CD11a Lymphocyte 
function-associated 
antigen 1 
0,6 (0,3) allophycocyanin 
(APC) 
R&D Systems, 
Minneapolis, MN, 
USA 
CD14 Serum 
lipopolysaccharide 
binding protein 
0,3 (0,2) phycoerythrincyanine 
(PECy7) 
BD Biosciences 
CD19 B lymphocyte-
lineage 
differentiation 
antigen 
0,3 (0,2) PECy7 BD Biosciences 
CD34 Siaomucin-like 
adhesion molecule 
35,4 (2,4) APC Immunotools, 
Friesoythe, Germany 
CD45 Leukocyte common 
antigen 
1,4 (1,4) APC BD Biosciences 
CD54 Intercellular adhesion 
molecule 1 
6,6 (7) fluorescein 
icothiocyanate 
(FITC) 
BD Biosciences 
CD73 Ecto-5’-nucleotidase 96,7 (98,8) PE BD Biosciences 
CD80 B-lymphocyte 
activation antigen B7 
0,4 (0,5) PE R&D Systems 
CD86 B-lymphocyte 
activation antigen 
B7-2 
0,3 (0,4) PE R&D Systems 
CD90 Thy-1 (T cell surface 
glycoprotein) 
99,7 (99,9) APC BD Biosciences 
CD105 SH-2, endoglin 97,5 (97,7) PE R&D Systems 
HLA-DR Major 
histocompatibility 
class II antigens 
0,6 (0,5) PE Immunotools 
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2.2.2. Preparation of AM 
	
The AMs used in this study were preserved and prepared by Panu Nordback (M.D. BioMediTech, Tampere, 
Finland) for his previous project (32). The AM was manually separated from donor placenta and then 
washed with 0,9% NaCl to remove blood clots and chorion remnants. The washed AM was then cut into 
suitable pieces and preserved overnight at +4°C in 10% Dulbecco's Phosphate-buffered Saline-solution 
(DPBS [Lonza Inc.]) containing antibiotics (2.5μg/ml amphotericin B [Invitrogen Ltd.], 5.0μg/ml penicillin 
[Invitrogen Ltd.], 50μg/ml streptomycin [Invitrogen Ltd.] and 100μg/ml neomycin.). For the removal of the 
epithelial layer, AM was incubated overnight with 40mg dispase (Invitrogen Ltd.) in 40ml of DMEM/F-12 
(Invitrogen Ltd.) solution containing 100U/ml penicillin, 100μg/ml streptomycin and 250ng/ml amphotericin 
B. After overnight incubation, AM was manually scraped to ensure the complete removal of the epithelial 
layer, which was verified by microscopic inspection. Dispase-processed AM was washed 10 times with cold 
DPBS to remove dispase. AM was then put into plastic containers along with DPBS-glycerol solution and 
cryopreserved at -80° for further use. Before seeding, AM was thawed in +37° and then rinsed with 0,9% 
NaCl to remove DPBS-glycerol solution in a large Petri dish. Then AM was cut manually into desired sizes 
using sterile scalpels and tweezers (Figure	4Figure	5). The different sides of AM were indistinguishable with 
the bare eye, nor were any remarkable differences seen under light microscope. Thus AM was plated at 
random into the culture dishes, though all wells of the same culture dish were always plated with the AM 
same side up. 
 
 
 
 
 
 
 
 
  
Figure	5	-	Spreading	of	AM	before	cutting	using	a	
large	Q-tip 
Figure	4	-	Cutting	of	AM,	the	white	paper	circle	is	
underneath	the	Petri	Dish	and	used	to	model	the	
size	of	the	well	of	the	multidish	
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2.2.3. Multidish cultivation 
	
Cell cultivation on AM was conducted in untreated 6-well multidishes for three weeks to allow free 
formation of structures. The bottom of each well was covered entirely with AM. Both rows were plated in 
the following order: ASC, HUVEC, ASC and HUVEC (Figure	6, Figure	7).  
 
 
The desired cell amount for ASCs was 20 000c/cm2 and 10 000c/cm2 for HUVECs.  The area of each well is 
approximately 1,92cm2, thus 38 400 of ASCs and 19 200 of HUVECs were seeded into their designated 
wells, along with 3ml of medium. During seeding and the first day of cultivation, both cell types received the 
same medium they had in the culture flasks to ensure attachment to AM. ASCs received basic medium and 
HUVECs endothelial medium and the combination wells received 1,5ml of both media. After one day, the 
media were discarded and fresh media were applied. The top row received adipose medium (ADM) 
(Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12 [DMEM/F12, Invitrogen Ltd.], 5% human 
serum [Cambrex], 1% L-glutamine [Invitrogen Ltd.], 1% penicillin-streptomycin mixture [Invitrogen Ltd.], 
1µM dexamethasone [Sigma], 100mM insulin [Sigma], 17µM pantothenate [Sigma], and 33µM biotin 
[Sigma Aldrich]) and the bottom row endothelial medium. The top row also received 0,005% isobutyl-
methylxantine (IBMX) after the first day of seeding to promote ASC differentiation. IBMX were given to the 
top row only once. The media were replaced twice a week and during those days, the multidishes and wells 
were photographed to document progress. The multidishes were photographed with a regular camera and the 
wells were photographed with a light microscope. After three weeks, the AMs were used for: quantitative 
PCR (qPCR), histological preparation, micro-CT or immunofluorescence imaging. The HUVECs were 
USPIO-labeled to enable micro-CT imaging. 
 
ASC	+	AM	+	
ADM	
	
HUVEC	+	AM	+	
ADM	
	
ASC	+	HUVEC	+	
AM	+	ADM	
	
ASC	+	AM	+	EM	 HUVEC	+	AM	+	EM	
ASC	+	HUVEC	+	
AM	+	EM	
Figure	7	-	Schematic	diagram	of	multidish	cultivation 
Figure	6	-	Multidish	cultivation,	the	top	row	has	received	adipose	
medium	and	the	bottom	row	endothelial	medium 
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2.3. Assay methods 
 
2.3.1. RNA isolation, reverse transcription and quantitative real-time polymerase chain 
reaction 
	
RNA isolation was conducted by using NucleoSpin RNA (Macherey & Nagel GmbH & Co) kit and 
protocol. After three weeks of cultivation, the amniotic membranes were transferred into individual 
Eppendorf test tubes and 350μl of RA1 and 3,5μl of β-mercaptoethanol were added into each tube. The tubes 
were put into -70°C deep freeze before further RNA isolation, due to scheduling reasons. The rest of the 
RNA isolation was done in one day, according to the protocol. The amniotic membrane and lysisbuffer were 
first centrifuged through a filter, and then the lysate was homogenized with 350μl of ethanol. The 
homogenized lysate was centrifuged through a RNA column, after which the lysate was discarded and the 
column was kept. 350μl of membrane desalting buffer was added to the column and centrifuged. The DNase 
reaction mixture was prepared by mixing 10μl of reconstituted rDNase and 90μl of reaction buffer for DNase 
to each sample, after which 95μl of the mixture was applied to each column and incubated in room 
temperature (RT) for 15 minutes. After incubation, the rDNase was inactivated by the RAW2 buffer and 
centrifuged. The RAW2 buffer was then washed twice with the RA3 buffer. After the second wash and 
centrifugation, the column was placed into a nuclease-free collection tube and eluted with 60μl of RNase-
free H2O and centrifuged. After elution, the samples were kept on ice, also during reverse transcription and 
qPCR. The concentration of the eluted RNA was tested with the Nanodrop spectrophotometer, after which 
the samples containing <4ng/μl of RNA were excluded from reverse transcription. 
Before reverse transcription, the RNA samples were diluted to the concentration of 100ng/μl using RNA-free 
H2O. The samples whose concentration were <100ng/μl were left undiluted. The reverse transcription 
Master Mix was made with the following recipe for each of the RNA samples: 10 x reaction buffer (6μl), 25 
x dNTPs (2.5μl), 10 x random primers (6μl), distilled water (12.5μl) and MultiScribe Reverse transcriptase 
3μl. The Master Mix was prepared in a room, which was forbidden from RNA/DNA samples to prevent 
contamination. 30μl of each diluted RNA sample and 30μl of the Master Mix were pipetted into individual 
Eppendorf test tubes and then put through PCR. The finished cDNA was then put into a -10°C freezer to 
await cDNA PCR.  
Quantitative real-time polymerase chain reaction (qPCR) was conducted with the Applied Biosystems 7300 
Real-Time PCR System. QPCR reveals the amount of a specific DNA sequence in a sample. QPCR operates 
by the same core principle as regular PCR. By raising the temperature, the DNA double strand opens and 
allows primers to seek out the desired sequence. The primers are able to anneal to the DNA strand once the 
temperature is lowered. DNA polymerase on the other hand needs a higher temperature to be able to 
transcribe a new strand of complement DNA. The aforementioned describes a PCR cycle, which repeats as 
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many times as programmed. In qPCR, pairing the cDNA (or DNA) sample with specific primers, DNA 
polymerase, deoxynucleotide triphosphates (dNTPs) and fluorescent dye in alternating temperatures lead to 
the production of the desired DNA sequence. The fluorescent dye attaches itself to products of the PCR, thus 
the amount of fluorescence released is directly proportional to the amount of newly synthesized DNA. Since 
there is an abundant amount of primers to cDNA, the amount of DNA produced in each cycle is directly 
proportional to the initial amount of cDNA in the sample. The more cDNA the sample contains, the more 
fluorescence will be achieved in fewer cycles. The threshold for fluorescence detection is set, and it is 
measured how many cycles are needed to reach the threshold (quantitation cycle, Cq). Standard samples, 
whose DNA concentration are known and vary from each other, are also put through qPCR. The Cq of the 
test samples is compared to the Cq of the standards, and the initial amount of cDNA can be calculated. (33) 
In this study, the qPCR Master Mix for each sample was: SYBR green Master Mix (7.5μl, Applied 
Biosystems), forward primer (0.5μl), reverse primer (0.5μl) and distilled water (5.5μl). The cDNA sample 
was diluted in the ratio of 1:1 with distilled water before the Master Mix was added. Each qPCR plate 
included one no template control (NTC) in the form of distilled water and five standards of different 
concentration. Each sample, NTC and standard was pipetted into three individual qPCR wells to minimize 
pipetting-related errors.  
The genes that were quantified in this study were: RPLP0, AP2, PPAR-γ, vWF and ANGPT1. RPLP0 
encodes a component of the 60S subunit of ribosomes, making it a housekeeping gene, which is expressed in 
virtually all cells. Since RPLP0 expression is so common, it is used as a reference gene, to which the 
expressions of other genes are compared. (30) AP2 encodes adipocyte protein 2, a carrier protein for fatty 
acids, thus AP2 expression is usually abundant in adipocytes(34). PPAR-γ encodes peroxisome proliferator-
activated receptor gamma, a nuclear receptor involved in adipocyte differentiation (30). The vWF gene 
encodes von Willebrand factor, a glycoprotein involved in hemostasis. VWF is both produced and stored in 
HUVECs. (35)  Lastly, ANGPT1 encodes angiopoeitin-1, a glycoprotein involved in angiogenesis (31). The 
sequences used can be found in Table 3. 
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Table	3	-	Oligonucleotide	sequences	used	for	qPCR 
Gene Accession 
number 
Primer 
Human ribosomal protein, 
large, P0 (hRPLP0) 
NM_001002 
 
Forward 5'-AAT CTC CAG GGG CAC CAT T-3' 
Reverse 5'-CGC TGG CTC CCA CTT TGT-3' 
Human adipocyte protein 2 
(AP2) 
NM_001442 
 
Forward 5’-GGTGGTGGAATGCGTCATG-3’ 
Reverse 5’-CAACGTCCCTTGGCTTATGC-3’ 
Human peroxisome 
proliferator-activated receptor 
gamma (hPPAR-γ) 
 Forward 5’-CAGTGTGAATTACAGCAAACC-3’ 
Reverse 5’-ACAGTGTATCAGTGAAGGAAT-3’ 
Human angiopoietin 1 
(hANGPT-1) 
NM_001146 
 
Forward 5’-TGCAAATGTGCCCTCATGTTA-3’ 
Reverse 5’-TCCCGCAGTATAGAACATTCCA-3’ 
Human von Willebrand factor 
(hvWF) 
 Forward 5´-AGAAACGCTCCTTCTCGATTATTG-3' 
Reverse 5'-TGTCAAAAAATTCCCCAAGATACAC-3´ 
 
 
2.3.2. Ultrasmall superparamagnetic iron oxide labeling and micro-CT 
	
USPIO labeling always took place three days prior to seeding. On the first day, HUVECs were detached 
from the culture flasks and counted. The protocol used in this study called for 1000μg of USPIOs to 100 000 
cells. The USPIO stock was 25mg/ml and the amount needed was always first diluted to a to working 
solution of 1mg/ml with EM. The amino acid poly-D-lysine (PDL) was used to ease uptake of USPIO 
particles into the cells. (36) The ratio of PDL to HUVECs was 3750μg to 100 000 cells. The PDL was mixed 
with the working solution of USPIO and EM. The mixture was incubated in RT for 30 minutes and gently 
vortexed every 10 minutes. After incubation, the working solution was diluted to a final solution of 
200μg/ml with EM. The HUVECs were put into new culture flasks along with the final solution. After two 
days of incubation in +37°C, the USPIO-PDL-EM was replaced with EM, and left to incubate for one more 
day in +37° before plating. 
The AMs that were subjected to micro-CT and histology were fixed with paraformaldehyde (PFA) after three 
weeks of culturing. The AMs were put into individual Eppendorf test tubes and 1ml of 4% PFA was added 
and incubated in RT for one hour. After incubation, the PFA was replaced with 1ml of 70% ethanol. The test 
tubes were put into +5°C storage while waiting for further analysis. 
Kalle Lehto (M.Sc., Tampere University of Technology) performed the micro-CT. Micro-CT employs the 
same technology as regular computer tomography, using X-ray to construct 3D cross-section images. The 
micro-prefix means that the resulting image can show micrometer range detail. Prior to the micro-CT, the  
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AMs were put into scaffolds made out of 1ml medical syringes. The barrel of the syringe was 
cut from the bottom and the tip of the plunger was also cut off and put back in the barrel 
backwards, so that the rubber end was pointing outwards. The AM was then put into the 
barrel, and another, fully intact plunger was inserted. The end result being the AM between 
two rubber ends of plungers inside the barrel (Figure	8). The AM was left as much space as it 
needed to rest freely. The space surrounding the AM was filled with 9% NaCl drawn via the 
tip of the syringe to prevent drying. The syringe was imaged in an upright position with 
parafilm stretched over the tip of syringe. All equipment, including the knife used to cut the 
syringes and the pieces of the syringe were wiped down with 90% ethanol to prevent pieces of 
metal transferring to the AM.  
 
2.3.3. Histology 
 
The same AMs that underwent micro-CT were prepared into histology slides by Sari Kalliokoski 
(BioMediTech). After micro-CT, the samples were stored in 70% ethanol until histology. In short, the 
samples were dehydrated, embedded in paraffin, and sectioned at 5-mm thickness. The sections were 
rehydrated and stained with hematoxylin and eosin (H&E). Hematoxylin acts as a basic dye, meaning it 
binds to acidic structures such as the nucleic acids, coloring them dark blue or purple. Eosin on the other 
hand acts as an acidic dye, binding to basic compounds, such as proteins and coloring them either pink, red 
or orange.  
 
2.3.4. Immunofluorescence microscopy and photography 
	
After three weeks of culture, two of the multidishes were subjected to immunofluorescence microscopy and 
photography. Immunofluorescence is based on the mechanism of antibodies attaching to their respective 
antigens, and when fluorescent-labeled antibodies are used, the emission can be detected through light 
microscopy. The different stains were photographed separately through their respective filters with the 
Olympus IX51 fluorescence microscope. Afterwards the photos were processed and combined using 
Photoshop.  
The staining was done with anti-von Willebrand factor antibody (anti-vWF AB), DAPI (4',6-diamidino-2-
phenylindole) and phalloidin. DAPI binds strongly to the A-T regions of the DNA, thus revealing the 
Figure	8	-	Micro-CT	
scaffold 
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nucleus of cells. In this study, DAPI was colored blue in the final pictures. Phalloidin on the other hand binds 
to filamentous actin (F-actin), which is a part of the cytoskeleton of cells. In this study, phalloidin was 
colored red in the final photos. 
As mentioned previously, vWF is a glycoprotein involved in hemostasis. HUVECs have been shown to both 
produce and store vWF (35). The staining of vWF was done indirectly by first labeling the AM with a 
primary rabbit anti-vWF antibody (ThermoFisher). Then the fluorescence was achieved with a secondary 
goat anti-rabbit antibody (ThermFisher). In this study, vWF was colored green in the final pictures. 
Before staining, the AMs were fixed with 0.1% Triton X-100 (Sigma) in 4% of PFA. 500μl of fixing solution 
was applied to each well to cover the bottom. After 15 minutes of incubation in RT, the fixing solution was 
discarded and the AMs were washed four times with DPBS. 1ml of DPBS was applied to each well after 
washes and the multidishes were wrapped in plastic and put into +5°C storage to wait for staining. Staining 
itself was done during the course of two days. On the first day, the DPBS was discarded and 300μl of 
blocking solution of 1% bovine serum albumin (BSA) was applied to each well and left to incubate in RT for 
one hour. The blocking solution is meant to block the nonspecific epitopes to prevent the staining antibodies 
to attach to them, thus reducing background staining noise. After blocking, the primary antibody incubation 
of vWF with rabbit anti-vWF antibody was done with the ratio of 1:500 antibody to 1% BSA. Other 
concentrations were tested earlier, including 1:100 and 1:200, but 1:500 was deemed sufficient enough. The 
multidishes were left to incubate in the primary antibody solution overnight in +5°C storage wrapped in tin 
foil. On the second day, the anti-vWF antibody was washed with DPBS. The secondary antibody incubation 
of goat anti-rabbit (1:800 of antibody to 1% BSA) and the direct staining of phalloidin (1:300 to 1% BSA) 
were done at the same time. The secondary incubation was left for one hour in RT (in the fume cupboard due 
to the toxic nature of phalloidin). After incubation, the wells were washed with DPBS and DAPI was applied 
in the ratio of 1:2000 to PBS (phosphate-buffered saline-solution). DAPI was incubated in RT for 5 minutes, 
after which it was washed with DPBS. DPBS was discarded and 1ml of Milli-Q purified water was added to 
each well, after which the wells were photographed using the Olympus IX51 fluorescence microscope. 
 
2.3.5. Tensile strength test 
	
AM was first laid onto a sheet of sterile nitrocellulose (NC) paper to keep it from balling up, making it easier 
to maneuver. Then the AM and the underlying paper were cut into suitable pieces to be placed into custom-
made cultivation scaffolds made of Teflon to keep it smooth and flat for the tensile strength test. The 
scaffolds are 2x7cm rectangles, consisting of a front and back piece, the AM and NC paper was placed 
between the pieces. The effect of cell cultivation on the mechanical properties of AM was tested with ASCs 
alone, the desired amount of cells was also 20 000c/cm2. The front piece has an opening in the center, where 
ASCs were seeded along with basic medium (Figure	9). The opening in the scaffold is approximately 1,5cm2, 
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thus 30 000 ASCs were plated to each AM. The scaffolds were placed in Petri dishes filled with enough 
basic medium to cover AM. The measurement points were one day after plating, one and three weeks after 
cultivation.  
 
 
 
 
 
 
The actual measurements took place in Tampere University of Technology and were assisted by Laura 
Johansson (M.Sc. Tampere University of Technology). The AM and paper were removed from its scaffold 
and cut into a dog biscuit shape (1x5cm) using a punch stencil (Figure	10). The dog biscuit shape provides 
larger end pieces, which were inserted into the clamps of the tension test machine. This arrangement was 
made to ensure that the pressure is focused in the middle of the sample, where the ASCs are. At each 
measurement point, two blank AM (along with nitrocellulose paper) were also measured as controls. The NC 
paper is suitable for the tension test, because it breaks easily and its elasticity is significantly lower than 
AMs, thus not affecting the tensile strength of AM. 
 
	
 
 
 
 
  
Figure	10	-	Culture	scaffold	
for	tensile	strength	test 
Figure	9	-	
Measurements	of	
tensile	strength	test	
sample 
Figure	11	-	Tensile	strength	test	–		
1:	cutting	of	AM	into	dog	biscuit	
shape	
2:	punch	stencil	and	cut	AM	+	NC	
paper	
3:	AM	in	between	tensile	test	
machine	
4:	the	desired	way	of	
nitrocellulose	paper	breaking	in	
the	middle,	leaving	AM	intact 
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3. Results 
	
	
3.1. Light microscopy 
	
 
	
 
Figure	12	-	Multidish	cultivation	week	1	x4	zoom,	first	row	was	in	ADM,	second	row	was	in	EM;	1:	ASC	+	ADM;	2:	HUVEC	+	ADM;	3:	
ASC	+	HUVEC	+	ADM;	4:	ASC	+	EM;	5:	HUVEC	+	EM;	6:	ASC	+	HUVEC	+	EM	
Figure	13	-	Multidish	cultivation	week	1	x	10	zoom,	first	row	was	in	ADM,	second	row	was	in	EM;	1:	ASC	+	ADM;	2:	HUVEC	+	ADM;	
3:	ASC	+	HUVEC	+	ADM;	4:	ASC	+	EM;	5:	HUVEC	+	EM;	6:	ASC	+	HUVEC	+	EM	
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Figure	14	–	Multidish	cultivation	week	3	x4	zoom,	first	row	was	in	ADM,	second	row	was	in	EM;	1:	ASC	+	ADM;	2:	HUVEC	+	ADM;	3:	
ASC	+	HUVEC	+	ADM;	4:	ASC	+	EM;	5:	HUVEC	+	EM;	6:	ASC	+	HUVEC	+	EM;	note	ASC	+	HUVEC	in	ADM	had	shrunk,	thus	couldn’t	be	
photographed	with	microscope	
 
Figure	15	-	Multidish	cultivation	week	3	x10	zoom;	first	row	was	in	ADM,	second	row	was	in	EM;	1:	ASC	+	ADM;	2:	HUVEC	+	ADM;	3:	
ASC	+	HUVEC	+	ADM;	4:	ASC	+	EM;	5:	HUVEC	+	EM;	6:	ASC	+	HUVEC	+	EM;	note	ASC	+	HUVEC	in	ADM	had	shrunk,	thus	couldn’t	be	
photographed	with	microscope	
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The multidishes were photographed with a Zeiss light microscope with white balance during every medium 
change, each well was photographed using x4 and x10 zoom. The photos featured in this study were of the 
ASC 2/15 P5 and HUVEC 1 P10 cell lines. There were four multidishes featuring the same cell lines and all 
of them underwent RNA extraction and qPCR after three weeks of culture. 	
During the first week of culture (Figure	12 and 13), cell formations could be seen in all the wells. ASCs 
demonstrated the typical MSC morphology, meaning a small cell body with long, thin, polygonal processes 
(37). ASCs could be seen in abundance in all the wells it was plated in (1, 3, 4 and 6 of both Figure	12 and 13), 
showing great vitality even in EM. In ADM, the ASCs appeared to grow randomly (1 of both Fig.12 and 13), 
but in EM, the ASCs seemed to grow in a tightly coiled spiral (4 of both Figure	12 and Figure	13). In the wells 
containing only HUVECs (2 and 5 of both Fig.12 and 13), there was thought to be tube formation, since 
distinct line structures could be seen. However, when compared to images of AM alone (Figure	16), the 
HUVEC wells looked very similar to the denuded AM, and we struggled to distinguish any cell structures 
with the bare eye. Curiously, the intense, natural pattern of AM was not seen in ASC wells, where ASCs 
could be easily spotted. In the combination wells (3 and 6 of both Fig.12 and 13), the spindle-shaped ASCs 
were easy to detect. Some HUVECs could be seen in the combination wells cultured in ADM (3 of both 
Fig.12 and 13), unlike the long and thin ASCs, HUVECs were small and round, cobblestone-like(38). 
HUVECs were again hard to distinguish in the combination wells cultured in EM (6 of both Fig.12 and 13). 
Interestingly, the ASCs of the combination wells cultured in EM grew tightly packed in vertical lines. 
 
By the third week of culture, ASCs had proliferated in both ADM and EM (1 and 4 of both Figure	15 and 
Figure	16). ASCs continued to grow randomly in ADM (1 of both Fig.14 and 15), the spiral-like growth in 
EM wasn’t as obvious as before, but a certain level of waviness could still be detected (especially in 
Fig.15.4). HUVECs were still difficult to distinguish from bare AM, nor was there much difference 
compared to the photos taken during the first week (2 and 5 of Fig.14 and 15). ASCs of the combination 
wells in EM maintained their vertical growth and became even more tightly packed (6 of both Fig.14 and 
15). The AM of combination wells in ADM had balled up, making photography impossible (3 of both Fig.14 
and 15). The shrinking of AM in the combination wells cultured in ADM was repeated in all of the 
Figure	16	-	Light	microscopy	photos	of	denuded	AM;	1:	x4	zoom;	2:	x10	zoom 
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multidishes. Contraction occurred nearly always in the ASCs in ADM wells and the combination wells in 
EM, but wasn’t as rapid and complete as in the combination wells in ADM. Milder shrinkage was seen in the 
ASCs in EM wells as well. The only wells where AM remained undisturbed for three weeks were the 
HUVECs-only wells. The shrinking of AM could be a sign of cell proliferation activity. 
 
3.2. QPCR 
	
 
After RNA isolation, the nucleic acid concentration of each sample was tested with the Nanodrop 2000 
spectrophotometer (Thermo Scientific). Although a concentration over 100ng/μl was desired, the results 
ranged from 0,6-182,49ng/μl. HUVECs in ADM had to be excluded from DNA translation in both sets, due 
to poor RNA concentration (0,6-1,69ng/μl). In the first set of results, every column represents one sample; 
the samples were of the ASC 2/14 P4, ASC 2/14 P3 and HUVEC P10 cell lines (Figure	17). In the second 
set, every column is the average result of 4 samples; the samples were the same ones featured previously in 
the light microscopy photographs (Figure	18). All results were compared to RPLP0, a housekeeping gene. 
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Figure	17	-	First	set	of	qPCR	results	in	logarithmic	scale.	Results	presented	in	brackets	are	actual	figures.	
ASC	BM	1	used	as	a	control	sample.	All	results	represent	one	sample.	ASC=adipose	stem	cell,	HUVEC=human	umbilical	vein	
entdothelial	cell,	BM=basic	medium,	ADM=adipose	medium,	EM=endothelial	medium.	
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AM with ASCs in BM was also included in the first set of qPCR as a control, with the relative expression of 
the ASC BM 1 sample marked as one for each gene (Figure	17).  
In the second set, one sample of ASCs in ADM was used as the control sample (ASC ADM 1), thus ASC 
ADM is the average of the three other samples. The results are displayed in logarithmic scale due to the 
different magnitude of results (Fig.18). Note the y-axis of vWF in the first set begins with 0.01 whereas 0.1 
is the first value in all of the other results (Fig.17).  
 
AP2 and PPAR-γ are both adipocyte-related genes and were expected to be abundant in the samples 
containing ASCs. In the first set, the highest relative expression of AP2 was in the ASCs in BM and ADM 
(18,1-25,3) samples. The non-control sample of ASCs in BM for some reason expressed AP2 25 times more 
than the control sample of ASCs in BM. Both samples of ASCs in BM behaved similarly in the expression of 
other genes. Compared to the control sample, the lowest concentration of AP2 was found in the combination 
well in EM (0.79). The other samples in EM (ASCs, HUVECs and combination) showed more AP2 
expression (5.6-7.2) than the control sample of ASCs in BM. The expression of AP2 did not correlate with 
the expression of PPAR-γ, which was expressed fairly the same in all samples (0.72-3.9). Compared to ASCs 
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Figure	18	-	Second	set	of	qPCR	results	with	logarithmic	scale.	Results	presented	in	brackets	are	actual	figures.		
ASC	ADM	1	used	as	a	control	sample.	ASC	ADM1	represents	one	sample,	ASC	ADM	the	average	of	three	samples	and	the	rest	an	
average	of	four	samples.	
ASC=adipose	stem	cell,	HUVEC=human	umbilical	vein	entdothelial	cell,	BM=basic	medium,	ADM=adipose	medium,	
EM=endothelial	medium.	
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in BM, samples of ASCs in EM (ASCs and combination) expressed PPAR-γ 3-4 fold (3.9 and 3.3), ASCs in 
ADM expressed PPAR-γ twice as much as the control sample (2.3-2.5) with the exception of one sample 
(ASC ADM Fig.17; 1.3). ASCs in BM and HUVECs in EM expressed PPAR-γ approximately the same 
amount as the control sample (0.72 and 1.2). In the second set, the most AP2 expression was found 
surprisingly in HUVECs in EM (131.4), whose expression was over tenfold the expression of the 
combination sample in ADM (10.0), which came second. There are no previous reports on AP2 expression 
by HUVECs. The expression of AP2 in ASCs in ADM was mild compared to the first set (2.6). PPAR-γ 
expression was rather similar also in the second set (0.46-1.4), the most expression was found in the 
combination sample in ADM (3.3) and ASCs in EM (3.9). HUVECs in EM showed the least expression of 
PPAR-γ (0.46) compared to the control sample. 
ANGPT-1 and vWF are genes involved in angiogenesis and hemostasis, and were expected to be widely 
expressed in samples containing HUVECs. In the first set, the most ANGPT-1 expression was seen in two of 
the ASCs in ADM samples (3.6-4.0), with the combination sample in ADM coming in a close third (3.5) 
(Fig.17). HUVECs in EM was only in fourth place (3.0), the combination well in EM faired only a little 
better than the control sample (1.1). The expression of ANGPT-1 did not correlate with the expression of 
vWF. VWF was expressed the most in HUVECs in EM, as expected (971.5). The result was thousandfold 
the vWF expression in all other samples (<1). In the second set, the control sample demonstrated the most 
expression of ANGPT-1. Out of the other samples, the combination sample in ADM expressed the most 
ANGPT-1 (0.86) by a minor lead over ASCs in ADM (0,67) (Fig.18), mirroring the results of the first set. 
HUVECs in EM and the combination sample in EM demonstrated significantly less expression than in the 
first set (<0.2). HUVECs in EM again expressed the most vWF (73982.9), the result repeated the 
thousandfold lead to the next greatest expression by the combination sample in EM (78.4). The combination 
sample in ADM also demonstrated a tenfold vWF expression compared to the control sample (11.6). The 
expression of vWF in other samples than HUVECs in EM was not seen in the first set of qPCR. 
In conclusion, the most replicable result was of vWF. HUVECs in EM clearly expressed the most vWF in 
both sets of qPCR, as expected. HUVECs in EM produced the least PPAR-γ in the second set, and also in the 
first set, if the non-control ASCs in BM sample is excluded. The overall expression of PPAR-γ and ANGPT-
1 was rather similar between samples in both sets of qPCR. The combination sample in ADM and ASCs in 
ADM seemed to produce the most ANGPT-1 in both sets, although HUVECs in EM also had notable 
expression in the first set, it was not seen in the second set. The dramatic AP2 expression of HUVECs in EM 
in the second set was not echoed by the first set. While the combination well in ADM had notable expression 
of all four genes (except vWF in the first set), it has to be noted that the expression of ANGPT-1 and vWF in 
both sets do not differ significantly from the expression found in ASCs in ADM, leading one to question how 
much of the expression can be credited to ASCs. The combination well in EM showed notable expression in 
both sets of adipocyte-related genes, but out of the vascularization-related genes, only vWF expression was 
seen clearly in the second set of qPCR. 
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3.3. Immunofluorescence photography 
	
 
 
	
One multidish featuring ASC 2/15 P9 and HUVEC 1 P13 was subjected to immunofluorescence 
photography after three weeks of culture. Each well was stained with DAPI, phalloidin and vWF, and 
photographed with x4 (Figure	19) and x10 (Figure	20) zoom. Each stain was photographed separately using 
Figure	19	-	Immunofluorescence	pictures	x	4,	each	well	stained	with	DAPI	(blue),	phalloidin	(red)	and	vWF	(green);	1:	ASC	+	ADM;	2:	
HUVEC	+	ADM;	3:	ASC	+	HUVEC	+	ADM;	4:	ASC	+	EM;	5:	HUVEC	+	EM;	6:	ASC	+	HUVEC	+	EM 
Figure	20	-	Immunofluorescence	pictures	x	10,	each	well	stained	with	DAPI	(blue),	phalloidin	(red)	and	vWF	(green);	1:	ASC	+	ADM;	
2:	HUVEC	+	ADM;	3:	ASC	+	HUVEC	+	ADM;	4:	ASC	+	EM;	5:	HUVEC	+	EM;	6:	ASC	+	HUVEC	+	EM 
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an Olympus IX51 fluorescence microscope. Afterwards the pictures were combined and colored with 
Photoshop. The blue color of DAPI shows the nucleus, the red color of phalloidin shows the cytoskeleton 
and vWF was colored green.  
A lot of nuclei could be seen in all wells except HUVECs in ADM (Figure	19.2 & Figure	20.2), which could 
be anticipated due to the lack of RNA during RNA isolation. Phalloidin-stained cytoskeleton could also be 
seen in each well. Green specks of vWF could only be seen weakly in a few of the wells. We expected to see 
vWF in the HUVEC wells, and some vWF activity was seen in the HUVECs in ADM well (Fig.19.2) and the 
combination well in EM (Fig.19.6) with x4 zoom. However the results were not replicable with x10 zoom. 
This is curious, since according to qPCR, vWF was greatly expressed in the HUVEC in EM wells and the 
combination in EM wells. 
The ASCs in ADM (Fig.19.1 & 20.1) seemed to grow randomly, like in the light microscopy pictures. A 
weak spiral-like growth could be seen in the ASCs in EM well with x4 zoom (Fig.19.4). The spiral-pattern 
was lost in x10 zoom, but the cytoskeleton of different cells were still parallel to each other, showing a 
regularity not seen in other wells (Fig.20.4); this was also comparable to the light microscope pictures taken 
of this well (4 of Fig.12-15). Some interesting line formations could be seen in the combination well in EM, 
visible in both x4 (Fig.19.6) and x10 (Fig.20.6) zoom. The lines seemed to be formed by nuclei and their 
respective cytoskeleton. The light microscope photo of this well showed the cells growing in a vertically 
tightly packed manner; this was not seen in the immunofluorescence pictures. 
  
3.4. Hematoxylin-eosin stained histology  
	
Two HUVECs in EM samples first underwent micro-CT and were then prepared into H&E stained histology 
slides. They were of HUVEC 1 cell line, passages 8 and 10. The histology pictures (Error! Reference 
source not found.) featured in this study were photographed with the same Zeiss light microscope that was 
used to document the multidish cultivation. The samples were photographed with x10 zoom and white 
balance; both pictures represent the same sample. 
 
Figure	21	-	H&E	stained	AM	+	HUVEC	+	EM	x	10	zoom 
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In the left picture is a cross-section of AM, cells could be seen lining the one side of the AM. The cells 
seemed to cover the entirety of AM in a single layer of cells. In the right picture, a cluster of cells could be 
seen in the AM matrix. Due to the straight edge seen on the right side of the cluster and the fraying seen on 
top, it could be assumed that the cells detached from the surface of AM during slicing. Interestingly, the 
detached cluster seemed to grow in many layers, as opposed to the picture on the left. 
 
3.5. Micro-CT 
	
The same samples that underwent H&E staining and histology slicing were first subjected to micro-CT. 
Figure	22Figure	23 consists of six stills of HUVECs in EM samples in micro-CT, together the pictures show 
the AM in 360° view. The HUVECs were labeled with USPIO-particles during cultivation to enable micro-
CT to detect possible tube formation. In the first session of micro-CT (Figure	22), a large, metallic cluster 
was seen near the top of the AM sample. We concluded that the metal was a remnant from the blade used to 
make the syringe scaffold. For the next session of micro-CT, the scaffold was wiped down carefully with 
90% ethanol to avoid contamination. Phase contrast was also applied to enable a better view of the USPIO-
particles. Unfortunately, the USPIO-particles remained unseen. A speck of red could be seen near the top of 
the AM, but when taken into consideration that 1000μg of USPIO was applied to every 100 000 HUVECs, it 
seemed odd that only one particle would remain after three weeks. The existence of HUVECs in EM 
cultivated on AM can be seen in the immunofluorescence (Fig.19.5 and 20.5) and the H&E stained histology 
pictures (Fig.21). One explanation could be that the HUVECs eventually pushed the foreign particles out 
during the three-week cultivation. Due to the large amount of dead HUVECs during initial cultivation, this 
scenario could be plausible. Another explanation could be that since the USPIO-particles were nano-sized, 
they couldn’t be detected in micro-CT, which is used to detect micro-sized details. But there have been 
studies, in which micro-CT successfully detected UPSIO-particles. (39) 
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Figure	22	-	Micro-CT	stills	of	AM	with	HUVEC	+	EM 
Figure	23	-	Phase	contrast	micro-CT	stills	of	AM	with	HUVEC	+	EM 
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3.6. Tensile strength 
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Figure	24	-	Stress/strain	graphs	of	tensile	strength	test,	top	left:	week	0	empty	samples,	top	right:	week	0	ASC	samples;	middle	left:	week	
1	empty	samples;	middle	right:	week	1	ASC	samples;	bottom	left:	week	3	empty	samples;	bottom	right:	week	3	ASC	samples	
The	samples	were	numerically	labeled,	the	first	number	represents	the	specific	time	point	(week	0,	week	1	and	week	3),	the	second	
number	represents	whether	ASCs	were	cultivated	(0	meaning	only	AM,	1	meaning	AM	and	ASCs),	the	last	number	differentiates	the	two	
samples	of	the	same	kind	tested	at	each	time	point	(sample	1	and	sample	2).	
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The AMs cultivated on top of NC paper in the Teflon scaffolds were subjected to tensile strength tests after 
one day (week 0), one week and three weeks of culture in BM. At each time point, four samples were tested, 
two empty samples with only AM and two samples of AM cultivated with ASCs. 
The AMs and NC paper were cut into dog biscuit shapes, whose wide ends were put between the clamps of 
the uniaxial tension test machine. The machine registered the elongation of the sample and the corresponding 
applied force. Engineering strain was calculated by determining the percentage of elongation to the original 
length of the AM sample, which was 3cm. Engineering stress was calculated by the dividing the force 
needed to break the AM by the cross-section area of the thinner middle piece. The area was dependent on the 
thickness of the particular AM sample, which was measured together with the NC paper, after which the 
thickness of the NC paper (1.33mm) was subtracted from the measurement. The thickness of the AM acted 
as the height of the area, and the width of the area was the same as the width of the thinner part of the dog 
biscuit, 0,5cm. The fracturing of NC paper and then AM were too low-energy to be registered by the tensile 
test machine, thus the breaking points were determined manually based on the data. 
Figure	24 features line graphs of each sample; in the graphs engineering stress is plotted against engineering 
strain, note the axis scale varies between the samples. On the left side of Figure	24 are the empty AM 
samples and on the right are the samples containing ASCs cultured on AM. Two empty samples and two 
ASC samples were tested during each time point. The samples were numerically labeled, the first number 
represents the specific time point (week 0, week 1 and week 3), the second number represents whether ASCs 
were cultivated (0 meaning only AM, 1 meaning AM and ASCs), the last number differentiates the two 
samples of the same kind tested at each time point (sample 1 and sample 2). The same labeling carries on in 
Figure	25, which depicts the individual properties of each sample.  
In Figure	24, all except the top two panels and the second empty sample of week three show two distinct 
peaks, the first one being the breaking point of the NC paper, and the second being the breaking point of 
AM. In the samples whose graph only show one peak, AM had broken simultaneously with the NC paper. In 
the first sample with ASCs of week 0, AM first tore incompletely along the NC paper, and broke into two a 
while later, thus the jagged shape of the graph. The overall shape of the two-peaked graphs look very similar, 
despite the samples tearing from different locations: the samples of week one broke near the middle, the 
samples of week three broke near the bottom.  
Figure	25 shows the individual properties of each sample, note the thickness of AM and engineering stress 
were displayed in logarithmic scale, due to the significantly different magnitude of results. Most of the AMs 
ranged between 0.01-0.02 mm in thickness, but the first empty sample of week 0 was 0.22 mm thick. The top 
four samples in applied force all broke along the NC paper, which can also be seen in Fig.24; more force was 
needed to break the NC paper than AM. The thickest AMs (week 0 empty samples and the week 1 second 
ASC sample) all broke at the same time as the NC paper, so any advantage of thickness was not seen. The 
elongation was obviously larger in the samples that broke independently from NC paper, ranging between 
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3.01-11.7mm. Since engineering strain is elongation divided by 30mm, the engineering graph correlates 
completely with the elongation graph. After one week of culture, the first empty sample elongated more than 
the other week one samples (11.7 mm versus 6.4-8.1 mm). After three weeks of culture, there was no 
significant difference in elongation nor applied force between the empty samples and the ASC samples. The 
ASC samples elongated more on week three than week one (9.4 mm average versus 7.7mm average). The 
week three ASC samples though, were thicker than the week one samples, which could be also seen in 
engineering stress; even though week three samples elongated more, week one samples endured more 
engineering stress (4.5E-3 MPa average versus 4.2E-3 MPa). The effects of ASC culture on AM was hard to 
determine due to the premature breaking of week 0 AMs, though it could also be a sign of improved tensile 
strength through culture, that AM broke independently from NC paper after at least one week of culture.	 
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Figure	25	-	Graphs	of	tensile	strength	tests,	top	left:	thickness	of	
AM	in	logarithmic	scale;	top	right:	elongation	of	AM;	middle	left:	
applied	force,	middle	right:	engineering	strain;	bottom	left:	
engineering	stress	in	logarithmic	scale	
The	samples	were	numerically	labeled,	the	first	number	
represents	the	specific	time	point	(week	0,	week	1	and	week	3),	
the	second	number	represents	whether	ASCs	were	cultivated	(0	
meaning	only	AM,	1	meaning	AM	and	ASCs),	the	last	number	
differentiates	the	two	samples	of	the	same	kind	tested	at	each	
time	point	(sample	1	and	sample	2).	
	
	 31	
4. Discussion 
	
	
This study had three main focuses: will ASC cultivation lead to adipose formation on AM, will the co-
culture of ASCs and HUVECs on AM lead to tube formation, and how does the culturing of cells affect the 
tensile strength of AM. The topics will be discussed separately. 
 
4.1. Adipose formation 
	
The cultivation of MSCs on AM has been done many times before, often with bone marrow MSCS, e.g. for 
the purposes of corneal (40,41) and dermal wound healing (42). In Roux et al.’s study, cultivation of BM-
MSCs and ASCs on the stromal side of AM was compared to each other. The stromal side was chosen due to 
the difficulties of removing the epithelial layer of AM and the lack of standardization of the process. The 
cells were cultured with α-modified Eagle’s medium (α-MEM) and 5% human platelet lysate. Researchers 
found that MSCs adhered 100% to AM even with higher seeding dose (up to 180 000 cells/cm2), which was 
remarkably better than to plastic (at 180 000 cells/cm2, 24% for BM-MSCs and 27% for ASCs). Both types 
of MSCs remained viable after 15 days of culture, seen by using Alamar blue assay. ASCs were not induced 
to form adipose tissue.  (43)   
In this study, while ASCs showed great viability in all the wells they were plated, the typical morphology of 
lipid droplet accumulations in differentiated adipocytes (44) weren’t seen in any of the microscope pictures 
(Fig. 12-15, 19 and 20). All ASC wells received IMBX after one day of plating; the IMBX was left for 24 
hours before it was removed. The lack of droplet formation could be due to the ambiguous adipocyte-related 
gene expression found in qPCR. In the first set of qPCR (Fig.17), AP2 was clearly expressed more in the 
ASCs in ADM samples, the same was not seen in the second set (Fig.18), where HUVECs in EM expressed 
the most AP2. PPAR-γ expression did not differ between ASC and HUVEC samples in both sets of qPCR.  
To the best of my knowledge, there are no previous studies conducted on whether ASC cultivation on AM 
will lead to adipose formation. In this study 0,005% IMBX was used to induce adipogenesis, other 
cultivation media and induction agents have been proven to affect ASC proliferation and differentiation and 
should be looked into in future studies  (45).   
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4.2. Angiogenesis and tube formation 
	
Angiogenesis is crucial for wound healing and tissue engineering, since necrosis will occur without sufficient 
oxygen and nutrient supply (27). Thus HUVECs were introduced to the cultivation in hopes of added 
angiogenesis. MSCs have been shown to promote angiogenesis when co-cultivated with HUVECs, 
producing more vessel-like structures than HUVECs alone. In Kachgal’s and Putnam’s study, ASCs and 
HUVECs were cultivated in 3D fibrin matrices using the same endothelial medium kit as in our study (46) . 
In Jiang et al.’s study, amniotic MSCs were co-cultivated with HUVECs, also in 3D fibrin matrices, using 
alfa-MEM (minimum essential medium eagle with alpha modification) (47). Both chose MSCs for their 
proteolytic abilities, which are needed in every step of angiogenesis. Both came to the same conclusion, that 
the co-culture of MSCs and HUVEC produced more vessel-like structures than HUVECs alone. (46,47)  
Merfeld-Clauss et al. co-cultured 2D monolayers of HUVECs with ASCs in endothelial growth basal 
medium and 5% fetal bovine serum. They hypothesized that HUVECs-only vessels are unstable and need a 
layer of stabilizing mural cells. The inclusion of ASCs did lead to longer-lasting vessel networks. (48)   
In this study, some cord formation was seen in the immunofluorescence pictures of the combination wells in 
EM (Fig.19.6 and 20.6). The expression of vWF in combination samples in EM was seen in the second set of 
qPCR (Figure	18). ANGPT-1 expression in combination samples in EM was the same as the control sample 
in the first set of qPCR (Figure	17) and actually lower than the control sample in the second set of qPCR 
(Figure	18). The similar angiogenic gene expression between HUVECs and ASCs doesn’t necessarily mean 
HUVECs demonstrated poor angiogenic activity, since ASCs have been shown to express angiogenic 
factors, including VEGF and interleukin-8 (49) .   
In Lin et al’s study, ASCs were cultivated on dopamine-coated electrospun fiber mats. Angiogenic properties 
of ASCs were tested by cultivation in DMEM with 2% fetal bovine serum with 50ng/ml of VEGF as an 
induction agent. ELISA results showed, that ANGPT-1 and vWF expression increased over time (1,3 -1,7 
times between day 3 and day 7), meaning ASCs do express ANGPT-1 and vWF.  (50)  VEGF was a 
component of the EM used in this study, but ASCs in EM did not show more angiogenic gene expression 
than ASCs in AM. This could be due to the different concentration of VEGF used in this study (0,1%). In 
Kingham et al’s study, ASCs were stimulated with basic fibroblast growth factor and platelet-derived growth 
factor for two weeks, after which RT-PCR revealed significantly increased VEGF-A and ANGPT-1 
expression. Unstimulated ASCs also released high levels of VEGF-A (20,92 ng/ml). The study also included 
HUVEC cultivation with either conditioned medium from stimulated ASCs or directly alongside stimulated 
ASCs, both leading to significantly more tube formation (length of continuously linked cells: 1,696μm in 
control sample, 2,346μm in conditioned medium and 3,667μm in direct contact with stimulated ASCs). (51)  
The combination wells in EM of this study did show some cord-like formations (Fig.19.6 and 20.6) in 
immunofluorescence photography, but the lack of green vWF in the pictures cast doubt on whether the cords 
seen in the immunofluorescence pictures are tube formation. 
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Based on the light microscopy pictures, HUVECs did not proliferate well in ADM. The same result could be 
seen in the immunofluorescence pictures and by the lack of RNA during RNA isolation. It could be 
concluded that ADM is not a suitable medium for HUVECs. Even though the combination samples in ADM 
showed promising cell viability in all of the assays, it is difficult to distinguish how much of the results are 
due to ASCs rather than HUVECs. For example, when the expression of ANGPT-1 and vWF are compared 
between the combination samples in ADM and ASCs in ADM, the results are quite similar (Fig.17 and 18). 
HUVECs alone in EM proliferated well (Fig.19.5 and 20.5), a lot of vWF expression was seen in qPCR. The 
combination well in EM was full of cells (Fig.12.6, 13.6, 19.6 and 20.6), but again, it was difficult to 
distinguish the amount of ASCs to HUVECs. The co-cultivation of ASCs and HUVECs did affect 
morphology; in ADM, AM balled up completely, in EM, the cells grew tightly packed in vertical lines (3 and 
6 of Fig.14 and 15). In summary, the true amount of HUVECs in combination wells was hard to determine; 
angiogenic activity was hard to interpret, due to angiogenic nature of ASCs, making it hard to compare to 
and distinguish from the expression of HUVECs. The USPIO-labeling of HUVECs was supposed to help 
identify them in micro-CT, and would have helped to determine the true amount of HUVECs in the 
combination samples. But as seen in the stills of micro-CT (Fig.21 and 22), none USPIO-particles were 
detected, either due to the expulsion of the particles by HUVECs or the sensitivity of the micro-CT.  
On the other hand, poor expression of angiogenic genes could be due to the properties of the AM. As 
previously mentioned, AM is a popular material for ocular reconstructive surgery, namely for its anti-
angiogenic properties e.g. inhibition of endothelial cell growth and suppression of corneal neovascularization 
(8,40,41).  All four groups of tissue inhibitors of metalloproteinase (TIMPs) have been found in the stromal 
layer of AM, produced by both the amniotic epithelial and mesenchymal cells. TIMPs inhibit matrix 
metalloproteinases, which are critical in angiogenesis. Other antiangiogenic proteins have also been found in 
AM, but TIMPs are also secreted by amniotic mesenchymal cells and can be found in the stromal layer. (10)  
Since the AMs used in this study were denuded, we could exclude the effects of amniotic epithelial cells, but 
the TIMPs of the stromal layer could be the reason behind the lack of angiogenesis. This could explain why 
ANGPT-1 was expressed less than expected. Also, in Choi et al’s study, HUVEC adhesion to AM was not as 
good as HUVEC adhesion to plastic (54.7% vs. 78.3%) (52) .  
 
4.3. Tensile strength 
	
The tensile strength tests were inconclusive due to the limited number of samples and the premature 
breakage of a couple of the samples. Even though it seems that the ASC samples elongated a little more after 
three weeks of culture than one week of culture, the sample size was simply too small to draw any 
conclusions (Fig.25). The vast variations in AM thickness (0.008 to 0.22mm) and the fact of the thickest 
samples tearing along NC paper made it difficult to determine the relationship between AM thickness and 
tensile strength. In a review study done in 2009, the average thickness of AM with epithelium was estimated 
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to be 50μm (0.05mm) (53) . The average thickness of denuded AM in our study was 0.04mm, which seems 
credible, despite the discrepancy among the samples. The location of where the harvested AM situated in the 
amnion cavity did not seem to affect AM tensile strength (53) . In Oyen et al’s study, the average peak force 
AM with epithelium could withhold without breaking was 1.57 ± 0.62N, and the average elongation was 
4.10 ± 0.40mm (54) . The average peak force in our study was 1.1N and 0.47N when the prematurely torn 
samples were excluded. The average elongation in our study was 6.90mm, which may insinuate that denuded 
AM is more flexible. In Amensag et al’s study, human vascular smooth muscle cells were cultivated on AM 
up to 40 days, after which AM strips were put between the clamps of an uniaxial tension test machine. 
Engineering stress was shown to progressively decrease over time (2,35 MPa day 0 and 0,40 MPa day 40). 
(55)  This study also came to the same conclusion (4.5E-3 MPa average day 0 versus 4.2E-3 MPa average 
day 21). Amensag et al had a higher cell density than our study (60 000 cells/cm2) (55) compared to 20 000 
ASCs/cm2, which could explain the more dramatic decrease in engineering stress. The other studies on fetal 
membrane tension strength measured AM alone, without any support like the NC paper used in this study  
(53,54) . NC paper was however necessary for this study, since ASC cultivation would have caused AM to 
ball up without the Teflon scaffold, and the placement of AM onto the scaffold was impossible without NC 
paper. 
 
4.4. Conclusion 
	
The objectives of this study were to cultivate 3D-grafts of AM with adipose tissue and vascular formation. In 
summary, adipose formation on AM was not seen, nor were certain tube formations. Tensile strength tests 
proved to be the opposite of our hypothesis, engineering stress actually decreased with time, though this was 
in line with previous findings  (55)  
The main weakness of this study was the inconsistency of results; more sets of each analysis assay are 
needed to achieve reliable results. Even though the stromal side of AM has also been shown to be a valid 
scaffold for cultivation (43)  a way of identifying the different sides of AM should be adopted for future 
studies, for the sake of consistency. Since the thickness of AM samples varied significantly, more samples 
are needed for reliable results. Tensile strength testing without nitrocellulose paper should also be attempted, 
since other tensile strength tests are mainly done with bare AM (54-56). The amount of viable HUVECs in 
combination wells should also be determined, since it was difficult to tell based on qPCR and photography. 
The possibility of nanotomography (nano-CT) should be explored, if USPIO particles can’t be detected even 
in nano-CT, the problem of HUVECs expelling USPIO particles should be looked into. 
To maximize possible tube formation, different induction agents should be looked into e.g.basic fibroblast 
growth factor and platelet-derived growth factor  (51),  to stimulate the angiogenic capacity of ASCs. The 
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same applies to ASCs as well, different cultivation medium and induction agents should be tested in future 
studies. 
In conclusion, AM is a feasible scaffold for cell cultivation, ASCs proliferated well in both media and 
combinations, HUVECs were certainly abundant in EM, perhaps also in the combination wells. Co-
cultivation of ASCs and HUVECs induced changes in morphology, even though tube formation was not 
achieved. The Teflon scaffold and NC paper enabled tensile strength measurements, which were technically 
a success. A larger sampling is needed for conclusive results. 
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